Screening and treatment of lipid disorders in people at high risk for future coronary heart disease (CHD) events has been recommended by the, 'United States Preventive Services Task Force (USPSTF)' especially for patients with known CHD. However, the role of screening in people with low to medium risk is controversial. On the basis of the effectiveness of treatment, the availability of accurate and reliable tests, and the likelihood of identifying people with abnormal lipids and increased CHD risk, screening appears to be effective in middle-aged and older adults and in young adults with additional cardiovascular risk factors.
Hyperlipidemia primary prevention
High cholesterol primary prevention
High cholesterol secondary prevention
Metabolic syndrome primary prevention
Metabolic syndrome secondary prevention
Diabetes mellitus type 2 secondary prevention
Diabetes mellitus type 2 primary prevention
Diabetes mellitus type 1 primary prevention